2 "/"

: Doxorubicin Teva 2 Mg/ml. ?  »
|
-

I.V

Solution For Injection

To produce regression in disseminated neoplastic conditions such as: - acute lymphoblastic leukemia, - acute myeloblastic leukemia, - Wilms` tumor neuroblastoma, - soft tissue and bone sarcomas, - breast carcinoma, - lymphomas of both Hodgkin`s and non-Hodgkin`s types, - bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types, - gastric carcinoma.

061 78 27503 00

Pharmachemie B.v., The Netherlands

10/2013 - 10/2023

.
, .
.
/
Doxorubicin hydrochloride 2 MG/ML
Vial glass type i x 5 ML 24
Vial glass type i x 10 ML 24
Vial glass type i x 25 ML 24
Vial glass type i x 100 ML 24

*

*

 

.

. :  »
 
" !
 
238
, ,